glp-1 inhibitor The Agonists and Obesity: How Diabetes Drugs are Changing Non-Diabetic Lives — tl;dr pharmacy GLP-1 Agonists - What is
Description
A meta-analysis [74] including the ELIXA [66], LEADER [44], SUSTAIN-6 [67], EXSCEL [68], REWIND [70], and AMPLITUDE-O [51] studies found that GLP-1RAs were associated with better renal outcomes: a 30% or 40% or more decrease in glomerular filtration rate, need for renal replacement therapy, end-stage renal failure, or death from kidney disease by 21%

Antidiabetic GLP-1 Receptor Agonists Have Neuroprotective Properties in Experimental Animal Models of Alzheimers Disease

It comes in two sizes (23 or 34 ounces), but I prefer the larger size because you dont need to fill it as often

GIP is a 42-amino acid polypeptide secreted from enteroendocrine K-cells that are found in the small intestinal epithelium [24,25]

If you have type 2 diabetes and are struggling to manage your blood sugar levels, especially if you are overweight or obese, GLP-1 shots may be an option to consider
